As investors focused on backing category-defining consumer brands, we are incredibly excited to support Plunge. Over the past four years, the company has scaled from a garage-built prototype to a dominant force in the wellness space, generating $90M in revenue—all without outside capital. This type of capital efficiency, product-market fit, and brand strength is rare, and we are thrilled to be part of their next phase of growth. When we met co-founders, Ryan Duey and Michael Garrett, we were immediately impressed by their vision, execution, and deep understanding of the market. Their ability to innovate across product, technology, and distribution while maintaining profitability speaks to their operational excellence. They have built a brand that resonates deeply with consumers and elite performance organizations alike, partnering with the likes of SpaceX, Equinox, and the U.S. Air Force. Plunge is unique in its category, leading not just in brand awareness but also in technological innovation. Their commercial-grade plunges solve critical pain points for B2B customers, and their IoT-enabled consumer models set a new standard in personalized wellness. Plunge is positioned to be the defining cold therapy company of our generation. We’re proud to be investing in Plunge and look forward to supporting their mission to bring cold exposure and contrast therapy to the mainstream.